Skip to main content

Genome Editing Research Group (GERG)

Mission

The mission of the Genome Editing Research Group is to collect and disseminate the fast-evolving knowledge in designer nuclease technologies, to undertake pilot research projects and to provide/publish the streamlined processes that could be used as guidelines by the interested Core Facilities to initiate Genome Editing technologies as services in their labs.

Current Membership

Kym Delventhal (Co-Chair) - Stowers Institute 

Elizabeth Sergison (Co-Chair)- Dartmouth College

Channabasavaiah Gurumurthy  - University of Nebraska Medical Center

Eric Kmiec - Gene Editing Institute

Shondra M. Pruett-Miller - St. Jude Children's Research Hospital

Timothy J. Dahlem - Recursion Pharmaceuticals

Gerald MarsischkyIndependent Consultant

Rich Cole (EB Liaison) - Wadsworth Center and School of Public Health State University of New York

 

 

 

Studies

GERG Survey 2017

GERG is collecting responses from scientists that are using genome engineering.  Contribute by answering the questions on the link below with your preferred methods for using CRISPR/Cas9 technology.  

The survey is now closed.  The collected data can be viewed here:  https://www.surveymonkey.com/results/SM-ZBM5L6768/

Results were summarized in a poster and presented at ABRF 2018:   CRISPR/Cas9 Methods:  Preferences from the Field 

 

Back to Top